| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chickenpox Vaccine | 2 | 2017 | 59 | 1.30 | Why? |
| Chickenpox | 2 | 2017 | 194 | 1.07 | Why? |
| Whooping Cough | 3 | 2018 | 201 | 0.86 | Why? |
| Mucocutaneous Lymph Node Syndrome | 5 | 2021 | 1645 | 0.82 | Why? |
| Urinary Retention | 1 | 2019 | 35 | 0.78 | Why? |
| Recreation | 1 | 2020 | 143 | 0.77 | Why? |
| Haemophilus Vaccines | 1 | 2018 | 76 | 0.72 | Why? |
| Vitamin K Deficiency | 1 | 2018 | 30 | 0.72 | Why? |
| Constipation | 1 | 2019 | 99 | 0.71 | Why? |
| Poliovirus Vaccine, Inactivated | 1 | 2018 | 72 | 0.71 | Why? |
| Pediatrics | 7 | 2020 | 2969 | 0.70 | Why? |
| Roseolovirus Infections | 1 | 2019 | 131 | 0.69 | Why? |
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2018 | 92 | 0.69 | Why? |
| Child Welfare | 2 | 2020 | 405 | 0.69 | Why? |
| Respiratory Syncytial Virus Vaccines | 1 | 2018 | 104 | 0.68 | Why? |
| Meningitis, Meningococcal | 1 | 2019 | 114 | 0.68 | Why? |
| Italy | 38 | 2021 | 38444 | 0.68 | Why? |
| Herpesvirus 6, Human | 1 | 2019 | 162 | 0.66 | Why? |
| Immunoglobulins, Intravenous | 3 | 2021 | 2705 | 0.64 | Why? |
| Pertussis Vaccine | 1 | 2017 | 89 | 0.64 | Why? |
| School Health Services | 1 | 2021 | 294 | 0.64 | Why? |
| Cerebellar Diseases | 1 | 2017 | 90 | 0.63 | Why? |
| Corpus Callosum | 1 | 2019 | 182 | 0.63 | Why? |
| Television | 1 | 2018 | 224 | 0.63 | Why? |
| Down Syndrome | 2 | 2020 | 397 | 0.63 | Why? |
| Societies, Medical | 10 | 2021 | 6907 | 0.63 | Why? |
| Immunization Schedule | 2 | 2021 | 1305 | 0.62 | Why? |
| Computers, Handheld | 1 | 2018 | 242 | 0.62 | Why? |
| Hepatitis B Vaccines | 1 | 2018 | 245 | 0.61 | Why? |
| Drug Resistance | 1 | 2018 | 395 | 0.60 | Why? |
| Phototherapy | 1 | 2017 | 138 | 0.60 | Why? |
| Vitamin K | 1 | 2018 | 263 | 0.60 | Why? |
| Central Nervous System Infections | 1 | 2017 | 158 | 0.59 | Why? |
| Vaccination | 7 | 2021 | 19050 | 0.59 | Why? |
| Practice Guidelines as Topic | 6 | 2021 | 15421 | 0.58 | Why? |
| Measles Vaccine | 1 | 2017 | 301 | 0.54 | Why? |
| Disease Transmission, Infectious | 4 | 2021 | 9044 | 0.54 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.54 | Why? |
| Child Development | 1 | 2018 | 352 | 0.53 | Why? |
| Mandatory Programs | 1 | 2018 | 291 | 0.53 | Why? |
| Mood Disorders | 1 | 2017 | 431 | 0.51 | Why? |
| Measles | 2 | 2019 | 608 | 0.51 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.49 | Why? |
| Appointments and Schedules | 1 | 2021 | 1204 | 0.49 | Why? |
| Respiratory Syncytial Virus Infections | 2 | 2021 | 1234 | 0.48 | Why? |
| Child | 37 | 2021 | 70012 | 0.48 | Why? |
| Pediatric Obesity | 1 | 2017 | 492 | 0.45 | Why? |
| Infant | 26 | 2021 | 30274 | 0.45 | Why? |
| Child, Preschool | 24 | 2021 | 36283 | 0.44 | Why? |
| Dermatologic Agents | 1 | 2017 | 489 | 0.44 | Why? |
| Non-alcoholic Fatty Liver Disease | 2 | 2017 | 907 | 0.43 | Why? |
| Overweight | 1 | 2017 | 916 | 0.43 | Why? |
| Health Care Costs | 1 | 2019 | 1007 | 0.42 | Why? |
| Hospitals, Pediatric | 8 | 2021 | 1792 | 0.37 | Why? |
| Guidelines as Topic | 2 | 2020 | 2844 | 0.37 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.36 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.35 | Why? |
| Consensus | 3 | 2021 | 6345 | 0.33 | Why? |
| Brain Diseases | 1 | 2019 | 1463 | 0.33 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.30 | Why? |
| Infection Control | 4 | 2021 | 23131 | 0.28 | Why? |
| Anxiety Disorders | 1 | 2017 | 2290 | 0.28 | Why? |
| Psoriasis | 1 | 2017 | 1739 | 0.25 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.24 | Why? |
| Acute Disease | 4 | 2019 | 6029 | 0.23 | Why? |
| Adolescent | 20 | 2021 | 86841 | 0.23 | Why? |
| Family Practice | 2 | 2018 | 472 | 0.21 | Why? |
| Pneumonia, Viral | 15 | 2021 | 243684 | 0.21 | Why? |
| Severity of Illness Index | 10 | 2021 | 48226 | 0.20 | Why? |
| Female | 38 | 2021 | 380317 | 0.20 | Why? |
| Exercise | 1 | 2020 | 6771 | 0.20 | Why? |
| Male | 36 | 2021 | 367725 | 0.20 | Why? |
| Humans | 52 | 2021 | 930598 | 0.18 | Why? |
| Prodromal Symptoms | 1 | 2019 | 133 | 0.18 | Why? |
| Vaccines, Combined | 1 | 2018 | 67 | 0.18 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.18 | Why? |
| Esophageal Atresia | 1 | 2017 | 24 | 0.18 | Why? |
| Haemophilus Infections | 1 | 2018 | 69 | 0.18 | Why? |
| Tetanus | 1 | 2018 | 61 | 0.18 | Why? |
| Tracheoesophageal Fistula | 1 | 2017 | 32 | 0.17 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.17 | Why? |
| Masks | 1 | 2020 | 8528 | 0.17 | Why? |
| Diphtheria | 1 | 2018 | 74 | 0.17 | Why? |
| Risk Assessment | 6 | 2018 | 25439 | 0.17 | Why? |
| Hypotension | 1 | 2021 | 392 | 0.17 | Why? |
| Fructose | 1 | 2017 | 52 | 0.17 | Why? |
| Bacterial Vaccines | 1 | 2018 | 139 | 0.17 | Why? |
| Postnatal Care | 1 | 2020 | 346 | 0.16 | Why? |
| Child, Hospitalized | 1 | 2021 | 556 | 0.16 | Why? |
| Antifibrinolytic Agents | 1 | 2018 | 150 | 0.16 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 317 | 0.16 | Why? |
| Contraindications, Drug | 1 | 2017 | 281 | 0.16 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.16 | Why? |
| Bullying | 1 | 2018 | 98 | 0.16 | Why? |
| Osteomyelitis | 1 | 2018 | 131 | 0.16 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.16 | Why? |
| Bordetella pertussis | 1 | 2017 | 117 | 0.16 | Why? |
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 6653 | 0.16 | Why? |
| Quarantine | 2 | 2020 | 18418 | 0.15 | Why? |
| Meningitis | 1 | 2017 | 163 | 0.15 | Why? |
| Treatment Refusal | 1 | 2018 | 211 | 0.15 | Why? |
| Infant, Newborn | 10 | 2021 | 23105 | 0.15 | Why? |
| Crime Victims | 1 | 2018 | 148 | 0.15 | Why? |
| Whole Exome Sequencing | 1 | 2017 | 437 | 0.15 | Why? |
| Coronary Artery Disease | 2 | 2021 | 2570 | 0.14 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.14 | Why? |
| Hyponatremia | 1 | 2019 | 371 | 0.14 | Why? |
| Neonatal Screening | 1 | 2017 | 285 | 0.14 | Why? |
| Pandemics | 18 | 2021 | 389249 | 0.14 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2021 | 846 | 0.13 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
| Policy Making | 2 | 2018 | 829 | 0.13 | Why? |
| Poliomyelitis | 1 | 2018 | 263 | 0.13 | Why? |
| Age Distribution | 3 | 2021 | 3567 | 0.13 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.13 | Why? |
| Breast Feeding | 2 | 2021 | 1585 | 0.13 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.13 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.13 | Why? |
| Sex Distribution | 2 | 2017 | 2083 | 0.12 | Why? |
| Desensitization, Immunologic | 1 | 2018 | 574 | 0.12 | Why? |
| Food Hypersensitivity | 1 | 2018 | 397 | 0.12 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.12 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.11 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.11 | Why? |
| Surveys and Questionnaires | 6 | 2021 | 43792 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.10 | Why? |
| Patients | 1 | 2018 | 1167 | 0.10 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.10 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.10 | Why? |
| Mothers | 1 | 2020 | 1624 | 0.10 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.10 | Why? |
| Encephalitis | 1 | 2017 | 797 | 0.10 | Why? |
| Neuroimaging | 1 | 2017 | 1106 | 0.10 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.10 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.10 | Why? |
| Mass Media | 1 | 2018 | 837 | 0.10 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.09 | Why? |
| Nurse's Role | 1 | 2017 | 614 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Emergency Service, Hospital | 4 | 2021 | 14232 | 0.09 | Why? |
| Physician's Role | 1 | 2017 | 853 | 0.09 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.09 | Why? |
| Health Literacy | 1 | 2018 | 1078 | 0.09 | Why? |
| Social Media | 2 | 2021 | 5798 | 0.09 | Why? |
| Referral and Consultation | 2 | 2021 | 4816 | 0.08 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.08 | Why? |
| Clinical Competence | 2 | 2019 | 3263 | 0.07 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.07 | Why? |
| Antibodies, Viral | 1 | 2018 | 51949 | 0.07 | Why? |
| Immunocompromised Host | 2 | 2020 | 5150 | 0.07 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.07 | Why? |
| Cohort Studies | 3 | 2017 | 36005 | 0.07 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.07 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.07 | Why? |
| Immunization Programs | 1 | 2017 | 2006 | 0.07 | Why? |
| Attitude of Health Personnel | 2 | 2019 | 4741 | 0.06 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2021 | 5164 | 0.06 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.06 | Why? |
| Intensive Care Units, Pediatric | 2 | 2021 | 1098 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.06 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.06 | Why? |
| Europe | 1 | 2018 | 12702 | 0.05 | Why? |
| Tachypnea | 1 | 2021 | 197 | 0.05 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.05 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.04 | Why? |
| Diarrhea | 2 | 2021 | 2743 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2020 | 689 | 0.04 | Why? |
| Measles virus | 1 | 2019 | 194 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.04 | Why? |
| Viral Vaccines | 1 | 2018 | 7560 | 0.04 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.04 | Why? |
| Feces | 2 | 2020 | 4235 | 0.04 | Why? |
| Parturition | 1 | 2021 | 514 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.04 | Why? |
| Vomiting | 1 | 2021 | 722 | 0.04 | Why? |
| Patient Care Planning | 1 | 2020 | 582 | 0.04 | Why? |
| Troponin T | 1 | 2021 | 771 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Neutropenia | 1 | 2019 | 388 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Encephalitis, Viral | 1 | 2019 | 355 | 0.03 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Societies, Scientific | 1 | 2017 | 414 | 0.03 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.03 | Why? |
| Adult | 7 | 2020 | 244371 | 0.03 | Why? |
| Genome, Human | 1 | 2017 | 400 | 0.03 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.03 | Why? |
| Macrolides | 1 | 2017 | 369 | 0.03 | Why? |
| Shock | 1 | 2021 | 1868 | 0.03 | Why? |
| Ambulatory Care | 2 | 2020 | 4947 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2020 | 1387 | 0.03 | Why? |
| Aspirin | 1 | 2021 | 1043 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 1165 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2020 | 8248 | 0.03 | Why? |
| Intensive Care Units, Neonatal | 1 | 2017 | 749 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2019 | 1316 | 0.03 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.03 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Pancreatitis | 1 | 2019 | 688 | 0.03 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2021 | 1671 | 0.03 | Why? |
| Proteome | 1 | 2020 | 1812 | 0.03 | Why? |
| Nasopharynx | 2 | 2020 | 10224 | 0.02 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.02 | Why? |
| Autoantibodies | 1 | 2020 | 2094 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Patient-Centered Care | 1 | 2017 | 860 | 0.02 | Why? |
| Medical Staff, Hospital | 1 | 2019 | 1258 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Communicable Disease Control | 1 | 2018 | 29620 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Aged | 3 | 2019 | 215776 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.02 | Why? |
| Needs Assessment | 1 | 2018 | 2352 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Cough | 1 | 2021 | 4891 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Nursing Staff, Hospital | 1 | 2019 | 1554 | 0.02 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.02 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Ultrasonography | 1 | 2021 | 4409 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2020 | 3630 | 0.02 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.02 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Public Health | 2 | 2018 | 16359 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Heart Failure | 1 | 2021 | 6638 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 9706 | 0.01 | Why? |
| Middle Aged | 3 | 2019 | 270681 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |